Published in Pharma Investments, Ventures and Law Weekly, August 7th, 2005
In April 2005, the company received notice from the AMEX Staff indicating that the company is below certain of AMEX's continued listing standards:
1) due to losses from continuing operations and/or net losses in two of its most recent fiscal years with shareholders' equity of less than $2 million, as set forth in Section 1003(a)(i) of the AMEX "Company Guide";
2) due to losses from continuing operations and/or net losses in 3 of its...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.